Huagongshe화공사 화학 정보 인쇄 보고서 · 연구 참고용
Sodium Hydroxide → {4-[2-(3,5-Dimethyl-pyrazol-1-yl)-acetyl]-piperazin-1-yl}-benzoic acid
참여 물질
| 역할 | 이름 | HCID | 투입량 |
|---|---|---|---|
| 반응물 | Sodium Hydroxide | HCID 14798 | — |
| 반응물 | 2-{4-[2-(3,5-Dimethyl-pyrazol-1-yl)-acetyl]-piperazin-1-yl}-benzoic acid methyl ester | HCID 66599729 | — |
| 용매 | MeOH tetrahydrofuran | HCID 21899815 | — |
| 생성물 | {4-[2-(3,5-Dimethyl-pyrazol-1-yl)-acetyl]-piperazin-1-yl}-benzoic acid | HCID 57516317 | 90% |
반응 단계
2-{4-[2-(3,5-Dimethyl-pyrazol-1-yl)-acetyl]-piperazin-1-yl}-benzoic acid methyl ester (0.848 g, 2.38 mmol) is dissolved in 10 mL of 1:1 THF/MeOH and 2 mL of 15% aqueous NaOH is added. The mixture is stirred overnight and then concentrated to dryness and suspended in 50 mL of H2O. The pH is adjusted to 4 by careful addition of conc. HCl. The aqueous phase is extracted with 3×100 mL of CH2Cl2. The combined organic phase is dried (MgSO4), filtered and concentrated to give 0.730 g of 2-{4-[2-(3,5-dimethyl-pyrazol-1-yl)-acetyl]-piperazin-1-yl}-benzoic acid in 90% yield.
출처 및 근거
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|---|
| 특허 번호 | US08362249B2 |
| 출처 데이터셋 | uspto-grants-2013_01 |
| ORD ID | ord-1f92fb063da64787a516e80e00229edc |
| 출처 메모 | uspto-grants-2013_01 |